RE: Scaff5530 Sep 2021 17:18
anthony - from rns
We are very pleased that the regulatory process to make our VISITECT® COVID-19 Antigen test available in the US professional use is progressing well. We believe we have a high-quality, high-performance product with significant global appeal and the US market, due to both its size and high barriers to entry, would be a very attractive commercial market for our product."